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Abstract: Oxygen–ozone (O2–O3) therapy is increasingly applied as a complementary/adjuvant
treatment for several diseases; however, the biological mechanisms accounting for the efficacy of
low O3 concentrations need further investigations to understand the possibly multiple effects on the
different cell types. In this work, we focused our attention on fibroblasts as ubiquitous connective
cells playing roles in the body architecture, in the homeostasis of tissue-resident cells, and in many
physiological and pathological processes. Using an established human fibroblast cell line as an
in vitro model, we adopted a multimodal approach to explore a panel of cell structural and functional
features, combining light and electron microscopy, Western blot analysis, real-time quantitative
polymerase chain reaction, and multiplex assays for cytokines. The administration of O2–O3 gas
mixtures induced multiple effects on fibroblasts, depending on their activation state: in non-activated
fibroblasts, O3 stimulated proliferation, formation of cell surface protrusions, antioxidant response,
and IL-6 and TGF-β1 secretion, while in LPS-activated fibroblasts, O3 stimulated only antioxidant
response and cytokines secretion. Therefore, the low O3 concentrations used in this study induced
activation-like responses in non-activated fibroblasts, whereas in already activated fibroblasts, the
cell protective capability was potentiated.
Keywords: oxygen–ozone therapy; cell proliferation; cell surface protrusions; nuclear factor erythroid
2-related factor 2 (Nrf2); heme oxygenase 1 (Hmox1) gene; interleukin-6; transforming growth factor
(TGF)-β1; fluorescence microscopy; scanning electron microscopy; real-time quantitative polymerase
chain reaction (RT-qPCR)
1. Introduction
In the last decades, the medical use of gaseous ozone (O3) has been progressively
increasing as a complementary/adjuvant treatment for several diseases [1–4]. O3 is a highly
unstable gas rapidly decomposing to oxygen, and it is applied for therapeutic purposes as
O2–O3 mixtures with low O3 concentrations. In fact, the mild oxidative stress induced by
low doses of O3 activates the nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated
Keap1-dependent pathway, which, in turn, stimulates gene expression of antioxidant
response elements (ARE) [5–7]. In fact, the exposure to low O3 concentrations promotes
an antioxidant cytoprotective response [8,9], which is consistent with the principle of
hormesis, i.e., “the beneficial effect of a low-level exposure to an agent that is harmful at
high levels” [10].
Despite the wide application of O2–O3 administration in clinical practice, the biological
mechanisms accounting for the therapeutic efficacy of O3 have been only partially unveiled,
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and further investigations are necessary to understand the multiple effects of this gas on the
different cell types in tissues and organs. As an example, appropriate O2–O3 gas mixtures
proved to exert an adipogenic effect in human adipose-derived adult stem cells [11] and
to reduce lipid loss in explanted adipose tissue [6]. In addition, it has recently been
demonstrated that, besides activating an antioxidant response through the Nrf2–ARE
pathway, O2–O3 gas mixtures are able to modulate cytokine secretion in T lymphocytes [7].
In the present work, we focused our attention on the fibroblast as a primary target
of O2–O3 therapy. In fact, it is worth noting that, whatever the administration route
(intramuscular, intra- and peri-articular or subcutaneous injection, topical bagging, rectal
or vaginal insufflation, autohemotherapy), O2–O3 mixtures inevitably act on fibroblasts;
actually, these are ubiquitous cells playing multiple roles in the architecture of organs and
the whole body, in the homeostasis of tissue-resident cells, and in many physiological (e.g.,
wound healing) and pathological processes, such as autoimmunity, fibrosis, and cancer [12].
It is therefore likely to expect that fibroblasts may be involved in the pathways activated by
O2–O3 administration and, in turn, in the therapeutic outcome.
An established human fibroblast cell line was used as a suitable in vitro model to
study the response to O2–O3 treatment under strictly controlled experimental conditions.
We investigated the structural and functional effects of low O3 concentrations on fibroblasts
in non-activated and lipopolysaccharide (LPS)-activated state with the aim to analyze the
response of these tissue-resident cells in a steady state or after the response to activating
stimuli (as it happens following tissue injury and/or inflammation, when they are com-
mitted to restore homeostasis [13]). We used gas mixtures with 10, 20, and 30 µg O3/mL
O2—concentrations usually applied in clinical practice. In order to explore a panel of struc-
tural and functional cell features, a multimodal approach was adopted, by combining light
(bright field and fluorescence) microscopy, scanning electron microscopy (SEM), Western




At 24 h after the gas exposure, the percentage of dead cells (estimated by the LDH
release) was similar (<6%) in all samples of non-activated fibroblasts, irrespective of the
treatment (p = 0.77, Figure 1). Similarly, no difference in cell death was found among
the LPS-activated samples (p = 0.11; Figure 1). LPS-activated control samples showed a
significantly lower value (<2%; p = 0.02) in comparison with the non-activated controls.
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2.2. S-Phase Evaluation
Under a conventional fluorescence microscope, bromodeoxyuridine (BrdU)-positive
fibroblasts appeared labelled in green, while DNA was counterstained in blue (Figure 2a–c).
At 24 h after the gas treatment, significant difference in the percentage of BrdU-positive
cells was found in non-activated fibroblasts (p = 0.01); post-hoc analysis revealed that only
cells exposed to 10 µg O3 showed a significantly increased proliferation rate in comparison
with the controls (p = 0.04) (Figure 2d). In LPS-activated fibroblasts, the exposure to O2 or
O3 did not alter the percentage of BrdU-positive cells (p = 0.52) (Figure 2d). LPS-activated
control samples showed a significantly lower cell proliferation in comparison with the
non-activated controls (p < 0.001).
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2.3. Wound Healing Assay 
The wound healing assay (representative images in Figure 3a,b) showed similar 
migration rates in all samples of both non-activated (Figure S1) and LPS-activated (Figure 
S2) fibroblasts 2 h (p = 0.21 and p = 0.33, respectively) and 6 h (p = 0.06 and p = 0.76, 
respectively) (Figure 3c,d) after gas exposure. After 24 h, the wound was completely 
healed in all samples (not shown). 
Figure 2. (a–c) Representative fluorescence icroscopy i ages of fibroblasts stained for ith
echst 3 42 (blue) (a), im unolabell d for B dU (green) (b), and merged (c). Bar, 100 µm. (d) Mean
values ± SE of percentages of BrdU-positive cells 24 h after the treatment (one experiment in t plica e).
The asterisk (*) indicates significant difference in comparison with the respective control (CT).
2.3. Wound Healing Assay
The wound healing assay (representative images in Figure 3a,b) showed similar mi-
gration rates in all samples of both non-activated (Figure S1) and LPS-activated (Figure S2)
fibroblasts 2 h (p = 0.21 and p = 0.33, respectively) and 6 h (p = 0.06 and p = 0.76, respec-
tively) (Figure 3c,d) after gas exposure. After 24 h, the wound was completely healed in all
samples (not shown).
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showed evident surface protrusions (Figure 4f–j). 
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Figure 3. (a,b) Representative inverted microscope images of fibroblasts at 2 h (a) and 6 h (b) of the
wound healing assay. Bars, 200 µm. (c,d) Means ± SE of percentages of cell-free areas of control (CT),
O2- and O3-treated non-activated (c) and LPS-activated (d) fibroblasts at 2 h and 6 h of the wound
healing assay (three experiments). No statistical difference was found for both non-activated and
LPS-activated samples.
2.4. Scanning Electron Microscopy
In non-activated condition, control and O2-treated fibroblasts appeared flattened and
irregularly polygonal in shape, with scarce filamentous protrusions of the cell surface
(Figure 4a,b). O3-treated fibroblasts aintained the polygonal shape but showed an
increase in the surface projections (Figure 4c–e). In LPS-activated condition, all samples
showed evident surface protrusions (Figure 4f–j).
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higher value was found in 10 µg O3-treated samples in comparison with all other samples
(p < 0.05) (Figure 7). Significant difference was found also in the LPS-activated state
(p = 0.004), where O3-treated samples secreted a significantly higher amount of IL-6 in
comparison with control and O2-treated samples (p < 0.05).
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In addition, LPS-activated fibroblasts secreted significantly lower amounts of TGF-β1
than non-activated control samples (p = 0.03) (Figure 8).
3. Discussion
In the present investigation, we evaluated the effects of the exposure to O2–O3 mix-
tures at low O3 concentrations on the structural and functional features of fibroblasts as
a cell type ubiquitously distributed in body tissues. Being primarily responsible for the
deposition and degradation of the extracellular matrix, fibroblasts play a key role in tissue
remodeling [14] and wound healing [12] and are also involved in the immune response and,
more generally, in the maintenance of tissue homeostasis [13]. The molecular and cellular
effects of low O3 concentrations were investigated in both non-activated and LPS-activated
fibroblasts, with the aim of getting information on the possibly differential response due to
the cell functional state.
LDH assay showed that the exposure to any of the gas mixtures used did not induce
significant cytotoxicity compared with the controls, in both non-activated and LPS-activated
fibroblasts, consistent with previous data on other cell types [6,7,11,15,16]. The LDH values
were lower for the LPS-treated than for the non-activated samples: this is likely due to
the activated state itself, as it has been demonstrated that pro-survival mechanisms are
stimulated in activated fibroblasts when these cells are committed to tissue repair [17].
Based on the evaluation of BrdU-positive S-phase cells, non-activated fibroblasts
proved to be stimulated by the exposure to 10 µg O3, suggesting that the eustress induced
by this mild concentration may promote cell growth, which is especially advantageous in
the post-injury tissue repair [18,19]. Accordingly, non-activated fibroblasts treated with
10 µg O3 showed a tendency (p = 0.06) to be more efficient than the other samples in the
wound healing assay, thus accounting for the observed positive effects of oxygen–ozone
therapy on wound healing [20,21].
The proliferation rate of LPS-activated fibroblasts was unaffected by the exposure to
any gas, but a significantly lower proliferation was found in LPS-activated fibroblasts in
comparison with the non-activated ones. This finding may be also related to the activated
state of the cells: consistent with the results in the present investigation, a decreased
proliferation rate (without an increase in the LDH release) has already been reported in
lung fibroblasts submitted to LPS treatment [22,23].
As already recalled, fibroblasts are involved in wound healing and mediate the for-
mation and remodeling of connective and epithelial tissues [24–26]. Migrating fibroblasts
are motile cells characterized by superficial cellular protrusions, such as lamellipodia and
filopodia [27]; in addition, filamentous projections are formed to remodel the collagen-rich
extracellular matrix during wound healing [28]. Under our experimental conditions, sur-
face protrusions were scarce in control and O2-treated non-activated fibroblasts, but they
evidently increased after O3 exposure. It is worth noting that small local changes in the
amount of reactive oxygen species (ROS), as induced by mild ozonation [15], may stimulate
the polymerization of cytoskeletal actin [29–31] that is essential to form cell protrusions and
promote adhesion [32,33]. However, the wound healing assay showed that the O3-induced
increase in the surface processes was not paralleled by a higher migration rate, consistent
with previous evidence that O3 exposure does not affect the cell migration capability [34].
On the other hand, O3 did not affect surface protrusions in LPS-activated fibroblasts,
whose control samples showed similar amounts of these membrane processes as the
O3-treated non-activated fibroblasts. This is consistent with the finding that cultured
fibroblasts treated with LPS increase their ROS production [35–37], which in turn affects
the organization of cytoskeletal proteins [29–31]. It can therefore be inferred that the low
O3 concentrations tested in the present study are able to induce activation-like changes
of the cell membrane in non-activated fibroblasts but do not affect already LPS-activated
fibroblasts, thus avoiding their overstimulation and the possible scarring of the extracellular
matrix [28].
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It is known that the administration of low O3 concentrations is able to restore impaired
Nrf2 pathways in many pathological conditions [38–44], thus inducing a cytoprotective
response accounting for the therapeutic potential of O3. The mechanism relies on the
stabilization of Nrf2 that mediates an antioxidant response by the Keap1/Nrf2 dependent
pathway [5]: ozonation prevents Keap1-mediated degradation of Nrf2 and promotes
its translocation to the nucleus [5,7]), where it activates the expression of ARE-driven
genes [5–7,16]. This enables an efficient and rapid transcription of antioxidant genes
without requiring a de novo synthesis of Nrf2. Accordingly, in the present study, the total
amount of Nrf2 protein was unchanged in non-activated fibroblasts, while the expression
of Hmox1 (i.e., the marker gene for the mild-O3-induced antioxidant response) increased
in samples treated with 20 µg O3, similarly as it was observed in nervous cells [16]. Genes
involved in oxidative stress responses were found to be upregulated also in primary
periodontal ligament fibroblasts treated with O3 ultrafine bubble water [45]. In LPS-
activated fibroblasts, the Nrf2 protein increased in 20 µg O3- and 30 µg O3-treated samples,
probably due to the combined oxidative stress due to LPS and O3 exposure. Consistently,
Hmox1 expression increased in a dose-dependent manner in O3-treated samples.
As stated above, fibroblasts are also involved in the regulation of the immune response
(with complex and mutual interactions with the cells of the immune system) and are able to
secrete different cytokines [46]. In particular, cultured fibroblasts secrete both IL-6 and TGF-
β1 [47], as observed in our experimental model. Our data are also consistent with previous
findings demonstrating that IL-6 secretion increases after LPS activation in vitro [48], while
cell proliferation is inhibited in an autocrine pathway [22].
IL-6 exerts a pleiotropic effect on a broad spectrum of biological events and partic-
ipates in the immune response as a potent pro-inflammatory cytokine involved in the
acute inflammatory response; on the other hand, it also coordinates anti-inflammatory or
repair-oriented activities essential for the resolution of inflammation [49]. In injured tissues,
IL-6 is a major systemic alarm signal [50–52] involved in the activation of a variety of local
and systemic host-defense mechanisms aimed at limiting tissue injury while stimulating
angiogenesis, collagen production and organization, keratinocyte proliferation, and leuko-
cyte infiltration [53–56]. The ability of low O3 concentrations to stimulate IL-6 secretion in
fibroblasts is therefore compatible with the efficacy of O2–O3 therapy in wound healing
and, more generally, in tissue repair [57–60]. In particular, low O3 concentrations seem to
stimulate IL-6 secretion in LPS-activated fibroblasts more efficiently than in non-activated
ones: this could be related to the activated state that makes the cells more responsive to
stimuli. Interestingly, pre-treatment with low O3 concentrations proved to reduce IL-6
secretion in skin fibroblasts receiving doxorubicin, thus preventing the inflammatory effect
of this potent cytotoxic drug [44]. Moreover, repeated and prolonged exposure of syn-
ovial fibroblasts isolated from patients affected by rheumatoid arthritis led to a decreased
production of IL-6 [61]. The immunomodulation potential of O3 on fibroblasts therefore
deserves detailed studies in view of targeted therapeutic approaches.
TGF-β1 also plays important roles as a key cytokine in the wound healing process,
where it acts bidirectionally [62], promoting the synthesis of various extracellular matrix
proteins [63–67] and potentiating angiogenesis [68–70], while inhibiting extracellular ma-
trix degradation [71] and inflammatory response [72,73]. TGF-β1 has been also reported to
enhance fibroblasts proliferation [74,75]. Therefore, its increased secretion in non-activated
fibroblasts following 10 µg O3 treatment may be related to the higher proliferation rate
found in this sample. On the other hand, LPS activation in vitro inhibits TGF-β1 produc-
tion [48], consistently with the very low amount of TGF-β1 found in our LPS-activated
fibroblasts. However, despite the inhibiting effect of LPS, 10 µg O3 proved to be capable of
increasing TGF-β1 secretion also in LPS-activated fibroblasts; on the contrary, 20 µg O3 and
30 µg O3 treatments induce a higher stress and a stronger TGF-β1 inhibition, likely due to
the activation of the Nrf2/ARE-mediated antioxidant signaling [76–78]. The stimulating
effect of low O3 concentrations on TGF-β1 secretion observed in our in vitro model is con-
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sistent with the upregulation of this cytokine reported in cutaneous wounds undergoing
accelerated repair following ozonated oil treatment [79,80].
4. Materials and Methods
4.1. Cell Culture and Treatment
Human lung fibroblasts (WI-26, ATCC) were chosen for the present study as a suitable
in vitro model previously used to investigate the effects of drugs on extracellular matrix
deposition [81] and remodeling [82] as well as the response to various stimuli [83–85].
The fibroblasts were grown in Dulbecco’s modified Eagle’s medium supplemented with
10% (v/v) fetal bovine serum, 1% (w/v) glutamine, 100 U of penicillin and 100 µg/mL
streptomycin (all reagents were purchased from Gibco, Walthem, MA, USA) at 37 ◦C in a
5% CO2 humidified atmosphere.
The cells were treated with O2–O3 gas mixtures produced from medical-grade O2
by an OZO2 FUTURA apparatus (Alnitec, Cremosano, CR, Italy) that allows photometric
real-time control of gas flow rate and O3 concentration. The concentrations of 10, 20, and
30 µg O3/mL O2 were chosen as these are usually administered in clinical practice and had
been shown to be non-cytotoxic for different cultured cells [7,11,15,16]. The treatment with
pure O2 was performed in order to discriminate the effect of O3 from O2 in the context of
the O2–O3 gas mixtures. Controls consisted in cells submitted to the same handling but
without exposure to gas.
The cells were trypsinized (0.25% trypsin in PBS containing 0.05% EDTA) (Gibco),
when sub-confluent. For Western blot analysis and RT-qPCR, samples of 4 × 106 cells were
suspended in 10 mL medium into a 20 mL polypropylene syringe, then 10 mL of gas was
added into the syringe using a sterile filter (Alnitec, Cremosano, CR, Italy) and the cell
suspension was gently mixed with the gas for 10 min to allow the full reaction of cells with
the gas [86]. For S-phase cells evaluation, SEM analysis, and wound healing assay, after
trypsinization, the cells were seeded on glass slides placed in multi-well microplates, let to
adhere for at least 24 h and then submitted to gas treatment as described in [87]. For LDH
and cytokine assays, 2 × 104 cells per 24-multi-well plate were seeded after gas treatment.
At 24 h, the medium was collected and stored at −80 ◦C until analysis.
Some fibroblast samples were pre-incubated with 1 µg/mL LPS for 24 h as previously
reported [23,88] in order to induce cell activation, and then processed as above.
4.2. Cytotoxicity
LDH, a cytosolic enzyme released by lysed cells, was evaluated as an estimate of the
cytotoxic effect of gas exposure by using the CytoTox96 nonradioactive assay (Promega,
Milan, MI, Italy). Cytotoxicity rate was estimated 24 h after the gas treatment in both
non-activated and LPS-activated fibroblasts. Aliquots of medium were collected for each
condition, placed in a 96-multi-well plate, mixed with the CytoTox 96 reagent and incubated
for 30 min at room temperature. After addition of the stop solution, the absorbance was
measured at 492 nm, and the data were corrected for culture medium background and
normalized to the maximum LDH release (i.e., the one of lysed samples).
4.3. S-Phase Evaluation
The percentage of S-phase cells was assessed 24 h after treatment in both non-
activated and LPS-activated fibroblasts, as a measure of the cell proliferation rate. The
cells (2 × 104 cells per 24 mm × 24 mm slides) were pulse-labelled with 20 µM BrdU
(Sigma-Aldrich, St. Louis, MO, USA) for 30 min at 37 ◦C, then fixed with 70% ethanol
and incubated for 20 min at room temperature in 2 N HCl to partially denature DNA;
after neutralization with 0.1 M sodium tetraborate (pH 8.2) (Sigma-Aldrich) for 3 min,
samples were washed in PBS, permeabilized for 15 min in PBS containing 0.1% bovine
serum albumin and 0.05% Tween-20 (Sigma-Aldrich), and incubated for 1 h with a mouse
monoclonal antibody recognizing BrdU (BD Diagnostics, Franklin Lakes, NJ, USA) diluted
1:20 in PBS. After two washes with PBS, samples were incubated for 1 h with an Alexa
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Fluor 488-conjugated anti-mouse secondary antibody (Molecular Probes, Invitrogen, Milan,
MI, Italy), diluted 1:200. The cell samples were washed with PBS, stained for DNA with
0.1 µg/mL Hoechst 33342 (Abcam, Cambridge, United Kingdom) in PBS for 10 min, and
finally mounted in PBS/glycerol (1:1). The percentage of BrdU-positive cells was evaluated
in 30 randomly selected fields (40×) per experimental condition. For observation of all
samples, an Olympus BX51 microscope (Olympus Italia S.r.l., Segrate, MI, Italy) equipped
with a 100 W mercury lamp was used under the following conditions: 450–480 nm excita-
tion filter (excf), 500 nm dichroic mirror (dm), and 515 nm barrier filter (bf) for Alexa Fluor
488; 330–385 nm excf, 400 nm dm, and 420 nm bf, for Hoechst 33342. Images were recorded
with a QICAM Fast 1394 Digital Camera (QImaging, Surrey, BC, Canada) and processed
with Image-Pro Plus software (Media Cybernetics, Inc., Rockville, MD, USA).
4.4. Wound Healing Assay
For the wound healing assay, 20 × 104 cells per well were seeded on 24 mm × 24 mm
slides. After 24 h, when the cells were confluent, the cell monolayers were scratched with
a sterile 200 µL pipette tip and immediately exposed to gas treatment. To evaluate cell
migration, images at 4× magnification were taken at 0 h, 2 h, 6 h, and 24 h post-treatment
using an inverted microscope (Leica DMIL, Leica Microsystems S.r.l., Buccinasco, MI, Italy)
equipped with a camera (Optika Microscopes, Ponteranica, BG, Italy): the cell-free area
was measured in a total of 12 randomly selected microscope fields per sample (4 fields in
3 independent experiments). The progressive reduction of the cell-free area was expressed
as percentage, considering the value at time 0 as 100%.
4.5. Scanning Electron Microscopy
For SEM analysis, 2 × 104 cells (both non-activated and LPS-activated fibroblasts) per
well were seeded on round slides of 12 mm in diameter. After 24 h, the cell monolayers were
gas exposed. At 24 h after the treatment, the cells were fixed with 2.5% glutaraldehyde in
PBS for 2 h at 4 ◦C, washed in the same buffer, post-fixed with 1% OsO4 at 4 ◦C for 1 h and
dehydrated with graded ethanol. The samples were then treated by a critical point dryer
(CPD 030, BAL- TEC AG, Balzers, Liechtenstein), mounted on metallic specimen stubs and
sputter-coated with gold (MED 010, BAL- TEC AG). SEM imaging was performed by an
XL30 ESEM (FEI Italia S.r.l., Milan, Italy). Using ImageJ software (NIH), the length of cell
surface facing the edge of the monolayers was measured both including and excluding cell
protrusions in 20 cells per sample; the ratio between the two values was then calculated
in order to obtain an index of cell surface irregularity (the higher the value, the rougher
the cell).
4.6. Western Blot Analysis
Non-activated and LPS-activated fibroblast samples were collected at 20 min post-gas-
treatment and immediately frozen in liquid nitrogen to be then placed at −80 ◦C. Proteins
were extracted according to standard procedures in RIPA buffer (150 mM NaCl, 10 mM
Tris pH7.5, 1% NP40, 1% deoxycholate, 0.1% SDS) supplemented with phosphatase and
protease inhibitors (Sigma-Aldrich).
Samples were resolved on Tris–glycine 4–20% gradient SDS-PAGE (BIO-RAD, Segrate,
MI, Italy), blotted on PVDF membrane (BIO-RAD), and developed with ECL Western
Blotting Substrate (Thermo Scientific, Rodano, MI, Italy). The following antibodies were
used: anti-Nrf2 1:1000 (ab62532 Abcam) and Actin 1:5000 (ab8226 Abcam).
4.7. Real-Time Quantitative Polymerase Chain Reaction
RNA was extracted from non-activated and LPS-activated fibroblast samples after
24 h after the gas exposure by using the Qiagen RNeasy Plus mini kit (ref. 74134) (Qia-
gen S.r.l., Milan, Italy). cDNA was generated by SuperScript™ III Reverse Transcriptase
(Invitrogen, cat. no. 18080093) (Thermo Fisher Scientific Inc., Waltham, MA, USA) and
amplified at qPCR with Applied Biosystems™ SYBR™ Green PCR Master Mix (Applied
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Biosystems™ 4309155) (Thermo Fisher Scientific Inc.) using 2 distinct sets of primers
specific for human Hmox1 (primers set 1: Forw: CCTAAACTTCAGAGGGGGCG, Rev:
GACAGCTGCCACATTAGGGT; primers set 2: Forw: AGTCTTCGCCCCTGTCTACT, Rev:
CTTCACATAGCGCTGCATGG). The Applied Biosystems Step-One Real-Time PCR System
was used for amplification (Thermo Fisher Scientific Inc.).
4.8. IL-6 and TGF-β1 Secretion
The amount of IL-6 and TGF-β1 secreted was evaluated in the culture medium of both
non-activated and LPS-activated fibroblasts 24 h after the gas treatment. For each sample,
4 × 105 cells/mL were treated with gas; experiments were performed four times per sample
and the medium was collected, centrifuged at 1500 g for 15 min, and the supernatants were
finally stored at −80 ◦C. Quantitation of IL-6 and TGF-β1 was conducted on a Luminex
Bio-Rad Bio-Plex 100 instrument (Bio-Rad Laboratories, Segrate, MI, Italy) coupled to the
Bio-Plex Manager software, v6.0, which allows measuring multiple proteins in a single well.
Briefly, 50 µL aliquots of undiluted cell medium were put in a 96-well plate (samples were
run in duplicate). Superparamagnetic microspheres (beads) conjugated with fluorophores
and antibodies against IL-6 and TGF-β were added to the assay wells. Incubation and
washing steps were performed as per manufacturer’s recommendations, then the plate
was loaded into the Luminex system for reading and signal quantitation.
4.9. Statistical Analysis
Data for each variable were presented as mean ± standard error (SE). Statistical com-
parison was performed by either the Kruskal–Wallis non-parametric test (cytotoxicity;
wound healing assay, cytokines) followed by the Mann–Whitney test for pairwise compari-
son or the one-way analysis of variance (ANOVA) test (S-phase evaluation; index of cell
surface irregularity, RT-qPCR) followed by Bonferroni’s post-hoc test. To RT-qPCR results,
the test for linear trend was also applied. Statistical significance was set at p ≤ 0.05.
5. Conclusions
Taken together, the results of the present study not only extend to fibroblasts the
notion that low O3 concentrations are safe for cells, but also provide original evidence
that the administration of O2–O3 gas mixtures induces multiple effects on fibroblasts,
depending on their activation state. In sum, in non-activated fibroblasts, O3 is able to
stimulate proliferation, formation of cell surface protrusions, antioxidant response, and
IL-6 and TGF-β1 secretion, while in LPS-activated fibroblasts, O3 stimulates antioxidant
response and cytokines secretion without affecting cell proliferation and motility. It is
therefore evident that the low O3 concentrations used in this study induce activation-
like responses in non-activated fibroblasts, whereas, in fibroblasts already activated by
LPS, the gas exposure potentiates the cell protective capability. Interestingly, most of the
effects observed in non-activated fibroblasts are due to the exposure to 10 or 20 µg O3, i.e.,
the concentrations that have been already found as optimal for safely inducing positive
response in various cell models [5–7,11,15,16]. This perfectly agrees with the low-dose
concept in the medical use of O3 [89,90], which is increasingly applied in clinical practice.
The simple in vitro model used in the present study was a suitable tool to shed light on
the specific responses of fibroblasts to low O3 concentrations; however, the observed effects
should be investigated in a more complex network of mutual interactions of different
cells and humoral factors, as it occurs in a living organism. Based on the present findings,
further in vivo studies will elucidate the contribution of fibroblasts in the response to
O2–O3 therapy, taking into account their multiple roles in tissue repair and homeostasis;
this will provide novel information to properly modulate the O3 administration protocols
for specific therapeutic needs.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/ijms221810133/s1, Figure S1: Wound healing assay of non-activated fibroblasts, Figure S2:
Wound healing assay of LPS-activated fibroblasts.
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